A detailed history of Discovery Capital Management, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Discovery Capital Management, LLC holds 30,700 shares of BNTX stock, worth $3.77 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
30,700
Previous 30,700 -0.0%
Holding current value
$3.77 Million
Previous $2.47 Million 47.79%
% of portfolio
0.5%
Previous 0.35%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$80.36 - $102.87 $2.47 Million - $3.16 Million
30,700 New
30,700 $2.47 Million
Q4 2021

Feb 14, 2022

SELL
$216.64 - $362.52 $2.97 Million - $4.97 Million
-13,700 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$205.93 - $447.23 $2.82 Million - $6.13 Million
13,700 New
13,700 $3.74 Million

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $29.8B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Discovery Capital Management, LLC Portfolio

Follow Discovery Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Discovery Capital Management, LLC , based on Form 13F filings with the SEC.

News

Stay updated on Discovery Capital Management, LLC with notifications on news.